Inventor · disambiguated record
Lori K. Taylor
Also filed as: TAYLOR LORI · TAYLOR LORI K · TAYLOR LORI KELL
11 granted patents·28 pending applications·136 citations·filing 2003–2023
93Inventor score
Files withABBVIE BIOTECHNOLOGY LTD19ABBOTT BIOTECH LTD8ABBOTT LAB S A3HOFFMAN REBECCA S3ANNEXON INC2
Top patents by PatentIndex Score
39 records- 0194US9090689B1Use of TNFα inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Jul 28, 2015·13 cites·21 claims
- 0294US8906373B2Use of TNF-alpha inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 9, 2014·20 cites·9 claims
- 0394US8889136B2Multiple-variable dose regimen for treating TNFα-related disordersHOFFMAN REBECCA S·Filed 2005·Granted Nov 18, 2014·25 cites·18 claims
- 0493US9085620B1Use of TNFα inhibitor for treatment of psoriatic arthritisABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Jul 21, 2015·12 cites·30 claims
- 0593US8986693B1Use of TNFα inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Mar 24, 2015·14 cites·8 claims
- 0693US8961974B2Multiple-variable dose regimen for treating TNFα-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Feb 24, 2015·12 cites·28 claims
- 0793US8961973B2Multiple-variable dose regimen for treating TNFα-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Feb 24, 2015·12 cites·30 claims
- 0892US9187559B2Multiple-variable dose regimen for treating idiopathic inflammatory bowel diseaseABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Nov 17, 2015·8 cites·30 claims
- 0990US9512216B2Use of TNFα inhibitorABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Dec 6, 2016·5 cites·16 claims
- 1090US9499615B2Multiple-variable dose regimen for treating idiopathic inflammatory bowel diseaseABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Nov 22, 2016·5 cites·28 claims
- 1190US9061005B2Multiple-variable dose regimen for treating idiopathic inflammatory bowel diseaseHOFFMAN REBECCA S·Filed 2012·Granted Jun 23, 2015·10 cites·28 claims
- 1277US2021347875A1MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERSABBVIE BIOTECHNOLOGY LTD·Filed 2020·Application pending·0 cites
- 1377US2021347874A1Multiple-variable dose regimen for treating tnfalpha-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2020·Application pending·0 cites
- 1471US2020017580A1Multiple-variable dose regimen for treating tnfalpha-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2019·Application pending·0 cites
- 1568US2019055308A1MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERSABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 1667US2014286940A1Treatment of tnfalpha related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 1767US2014286941A1Treatment of tnfalpha related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 1867US2008193466A1Treatment of Anemia Using TNFalpha InhibitorsABBOTT BIOTECH LTD·Filed 2008·Application pending·0 cites
- 1967US2014286939A1Treatment of tnfalpha related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 2066US2009304682A1Multiple-variable dose regimen for treating TNFa-related disordersHOFFMAN REBECCA S·Filed 2008·Application pending·0 cites
- 2165US2017022271A1Multiple-variable dose regimen for treating tnfalpha-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2016·Application pending·0 cites
- 2264US2013243763A1TREATMENT OF HIDRADENITIS SUPPURATIVA (HS) USING TNFalpha ANTIBODIESBANERJEE SUBHASHIS·Filed 2013·Application pending·0 cites
- 2364US2025313614A1Compositions and methods for treating ocular diseasesANNEXON INC·Filed 2023·Application pending·0 cites
- 2462US2015368335A1Treatment of tnf-alpha related disordersABBOTT BIOTECH LTD·Filed 2015·Application pending·0 cites
- 2561US2017044249A1MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERSABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 2660US2016376360A9Use of TNFalpha InhibitorABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 2758US2004136991A1Treatment of anemia using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 2858US2004131614A1Treatment of pulmonary disorders using TNFalpha inhibitorABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 2958US2024059765A1Compositions and methods for treating ocular diseasesANNEXON INC·Filed 2021·Application pending·0 cites
- 3058US2004126372A1Treatment of TNFalpha related disordersABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3158US2004126373A1Treatment of coronary disorders using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3258US2004151722A1Treatment of metabolic disorders using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3358US2004136990A1Treatment of pain using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3457US2004219142A1Treatment of skin and nail disorders using TNFalpha inhibitorsABBOTT LAB S A·Filed 2003·Application pending·0 cites
- 3557US2013243786A1Treatment of juvenile rheumatoid arthritis (jra)BANERJEE SUBHASHIS·Filed 2003·Application pending·0 cites
- 3657US2004136989A1Treatment of vasculitides using TNFalpha inhibitorsABBOTT LAB S A·Filed 2003·Application pending·0 cites
- 3757US2007202104A1Treatment of spondyloarthropathies using TNFalpha inhibitorsABBOTT LAB S A·Filed 2003·Application pending·0 cites
- 3845US2015050216A1Uses and Compositions for Treatment of PsoriasisWILLIAN MARY KAYE·Filed 2014·Application pending·0 cites
- 3943US2014243273A1Methods for treating inflammatory diseases and pharmaceutical combinations useful thereforVERTEX PHARMA·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →